Different Vitamin D Preparations & FGF23 in Humans

Completed · Not applicable

Conditions studied: Vitamin D Deficiency

In brief

Fibroblast growth factor 23 (FGF23) is a new hormone which controls phosphate and vitamin D levels in humans. Excess FGF23 is associated with an increased risk of death in patients with chronic kidney disease. In this study the investigators are investigating the effects of different forms of vitamin D on FGF23 levels in the blood in order to increase our understanding of how this important hormone works.

Key facts

Study ID
NCT00957879
Run by
Massachusetts General Hospital
People needed
42
Starts
2009-05-01
Expected to finish
2011-03-01
Last updated by the study team
2012-04-19

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.